@techcrunch.com 1 year ago
Nanopath is looking to drastically change medical diagnostics
@xconomy.com 4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com 5 years ago
Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M
@xconomy.com 6 years ago
Exact Sciences Beats Quarterly Forecasts, Sending Its Stock Price Up